As of close of business last night, VistaGen Therapeutics Inc’s stock clocked out at $5.40, up 2.27% from its previous closing price of $5.28. In other words, the price has increased by $+0.12 from its previous closing price. On the day, 940428 shares were traded. VTGN stock price reached its highest trading level at $5.74 during the session, while it also had its lowest trading level at $5.08.
Ratios:
To gain a deeper understanding of VTGN’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 30.75 and its Current Ratio is at 30.75. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.
On August 07, 2023, Maxim Group Upgraded its rating to Buy which previously was Hold but kept the price unchanged to $30.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Aug 07 ’23 when COMMODORE CAPITAL LP bought 775,756 shares for $23.15 per share. The transaction valued at 17,961,079 led to the insider holds 1,575,000 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VTGN now has a Market Capitalization of 145.69M and an Enterprise Value of 21.39M. For the stock, the TTM Price-to-Sale (P/S) ratio is 140.35 while its Price-to-Book (P/B) ratio in mrq is 1.18. Its current Enterprise Value per Revenue stands at 20.52 whereas that against EBITDA is -0.64.
Stock Price History:
Over the past 52 weeks, VTGN has reached a high of $24.71, while it has fallen to a 52-week low of $1.62. The 50-Day Moving Average of the stock is 4.74, while the 200-Day Moving Average is calculated to be 4.31.
Shares Statistics:
It appears that VTGN traded 288.58K shares on average per day over the past three months and 411.81k shares per day over the past ten days. A total of 27.03M shares are outstanding, with a floating share count of 24.29M. Insiders hold about 10.12% of the company’s shares, while institutions hold 55.25% stake in the company. Shares short for VTGN as of Mar 15, 2024 were 1.33M with a Short Ratio of 4.63, compared to 1.72M on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 4.94% and a Short% of Float of 4.95%.
Earnings Estimates
As of right now, 4 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of -$0.36 for the current quarter, with a high estimate of -$0.27 and a low estimate of -$0.46, while EPS last year was -$1.5. The consensus estimate for the next quarter is -$0.37, with high estimates of -$0.36 and low estimates of -$0.38.
Analysts are recommending an EPS of between -$1.46 and -$1.74 for the fiscal current year, implying an average EPS of -$1.6. EPS for the following year is -$1.96, with 4 analysts recommending between -$1.82 and -$2.07.
